Minnesota providers earned $630M in 340B revenue in 2023

Minnesota providers participating in the federal 340B Drug Pricing Program generated at least $630 million in net revenue in 2023, according to a new report from the state Department of Health. 

Advertisement

The program, which allows qualifying healthcare providers to purchase outpatient drugs at discounted prices, is a significant source of funding for many healthcare organizations in the state. 

Here are four key takeaways from the report:

  1. The state’s largest 340B hospitals accounted for about 80% of the total revenue, amounting to roughly $500 million. These hospitals made up just 13% of the reporting entities but filled the majority of prescriptions under the program. 
  2. Federally qualified health centers and similar safety-net clinics generated the least revenue from the program.
  3. The report showed that approximately $87 million, or 14% of total net 340B revenue, was generated through payments from Minnesota’s Medicaid programs.
  4. Covered entities paid more than $120 million to third-party administrators and contract pharmacies, representing 16% of the gross 340B revenue generated. 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.